Amneal Pharmaceuticals

Amneal launches new biosciences unit

Thursday, August 27, 2015

Amneal Pharmaceuticals has launched Amneal Biosciences, a wholly owned subsidiary. Amneal Biosciences will focus exclusively on the commercialization of high-barrier-to-entry generic and specialty pharmaceuticals such as injectables, oncologics and biosimilars to healthcare providers globally.

[Read More]